Latigo Biotherapeutics Revenue and Competitors
Employee Data
- Latigo Biotherapeutics has 41 Employees.
- Latigo Biotherapeutics grew their employee count by 52% last year.
Latigo Biotherapeutics's People
| Name | Title | Email/Phone |
|---|
Latigo Biotherapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 8 | 0% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 17 | 31% | N/A | N/A |
What Is Latigo Biotherapeutics?
Latigo Biotherapeutics Inc., headquartered in Thousand Oaks, CA, is a privately held clinical-stage biotechnology company developing best-in-class non-opioid pain medicines that target the fundamental mechanism of pain transduction. The company’s proprietary, in-house technology generates novel drugs against targets validated by human genetics using the most advanced artificial intelligence, machine learning, structure-based, and knowledge-based design techniques to optimize potency and selectivity. The company is backed by top-tier investors, including Westlake Village BioPartners, 5AM Ventures, Foresite Capital, and Corner Ventures.
keywords:N/A
N/A
Total Funding
41
Number of Employees
N/A
Revenue (est)
52%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Thousand Oaks
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $8.4M | 42 | N/A | N/A |
#2 | $10M | 43 | 8% | N/A |
#3 | $10.6M | 43 | 0% | N/A |
#4 | $5.2M | 45 | N/A | N/A |
#5 | $15M | 47 | 2% | N/A |